Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Prenetics Global Limited Class A Ordinary Share (PRE)

Prenetics Global Limited Class A Ordinary Share (PRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,146
  • Shares Outstanding, K 9,137
  • Annual Sales, $ 21,740 K
  • Annual Income, $ -62,720 K
  • 60-Month Beta -0.11
  • Price/Sales 1.32
  • Price/Cash Flow N/A
  • Price/Book 0.14
Trade PRE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.33
  • Most Recent Earnings $-0.52 on 04/01/24
  • Latest Earnings Date 06/03/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-6770 Blank Checks

    Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.60
  • Growth Rate Est. (year over year) +166,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.85 +1.75%
on 04/19/24
4.90 -40.82%
on 03/20/24
-1.71 (-37.09%)
since 03/19/24
3-Month
2.85 +1.75%
on 04/19/24
5.84 -50.34%
on 03/08/24
-1.57 (-35.12%)
since 01/19/24
52-Week
2.85 +1.75%
on 04/19/24
15.90 -81.76%
on 05/12/23
-9.32 (-76.27%)
since 04/19/23

Most Recent Stories

More News
Prenetics Global Limited (PRE) Gains As Market Dips: What You Should Know

Prenetics Global Limited (PRE) closed at $0.85 in the latest trading session, marking a +0.01% move from the prior day.

PRE : 2.90 (-9.09%)
Wall Street Analysts Look Bullish on Prenetics Global Limited (PRE): Should You Buy?

Based on the average brokerage recommendation (ABR), Prenetics Global Limited (PRE) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness...

PRE : 2.90 (-9.09%)
Prenetics Global Limited (PRE) Stock Sinks As Market Gains: What You Should Know

Prenetics Global Limited (PRE) closed at $0.83 in the latest trading session, marking a -0.59% move from the prior day.

PRE : 2.90 (-9.09%)
4 Medical Stocks to Buy as Rate Hike Cycle Nears End

We have narrowed our search to four U.S.-based medical stocks with attractive valuations. These are HROW, LSTA, OCUP and PRE.

PRE : 2.90 (-9.09%)
HROW : 10.45 (-3.69%)
OCUP : 1.6550 (-0.90%)
LSTA : 2.70 (-5.26%)
Prenetics Global Limited (PRE) Loses -24.21% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Prenetics Global Limited (PRE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings...

PRE : 2.90 (-9.09%)
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating

Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating

PRE : 2.90 (-9.09%)
Why Prenetics Global Stock Is Skyrocketing Today

The company announced a key FDA clearance.

PRE : 2.90 (-9.09%)
Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics

HONG KONG, Dec 16, 2022 - (ACN Newswire) - Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, is acquiring a majority stake of ACT,...

PRE : 2.90 (-9.09%)
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index

LONDON AND HONG KONG, Nov 30, 2022 - (ACN Newswire) - Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced that its...

PRE : 2.90 (-9.09%)
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance

LONDON AND HONG KONG, Nov 10, 2022 - (ACN Newswire) - Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced its unaudited...

HSBC : 40.52 (+0.32%)
PRE : 2.90 (-9.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Prenetics Group Limited is involved in genomic and diagnostic testing which is disrupting and decentralising healthcare with a focus on prevention, diagnostics and personalized care. It develops consumer genetic testing and early colorectal cancer screening; provides COVID-19 testing, rapid point of...

See More

Key Turning Points

3rd Resistance Point 3.50
2nd Resistance Point 3.36
1st Resistance Point 3.13
Last Price 2.90
1st Support Level 2.76
2nd Support Level 2.62
3rd Support Level 2.39

See More

52-Week High 15.90
Fibonacci 61.8% 10.91
Fibonacci 50% 9.38
Fibonacci 38.2% 7.84
Last Price 2.90
52-Week Low 2.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar